Moreover, carriers of GBA1 mutations might be at an increased risk of developing PD.[6,7] Even though the pathophysiology is not yet completely understood, GBA1 mutations lead to a dysfunction of the autophagy–lysosomal pathway and then to a decreased degradation of alpha-synuclein. Here, GBA1 is linked to Parkinson disease.